NCT02096874View on ClinicalTrials.gov

Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

June 30, 2015

Conditions
Non-proliferative Diabetic RetinopathyProliferative Diabetic RetinopathyDiabetic Macular Edema
Interventions
DRUG

Bevacizumab

Intravitreal injection of 1.25mg/0.05 cc each 5 weeks for the first 3 months then PRN for six month

Trial Locations (1)

11462

King Khaled Eye Specialist Hospital, Riyadh

All Listed Sponsors
lead

King Khaled Eye Specialist Hospital

OTHER_GOV

NCT02096874 - Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema | Biotech Hunter | Biotech Hunter